Recently-listed drug maker AFT Pharmaceuticals is banking on its main product, the painkiller Maxigesic, to drive the company's fortunes over the coming year.
Recently-listed drug maker AFT Pharmaceuticals is banking on its main product, the painkiller Maxigesic, to drive the company's fortunes over the coming year.